儿童癌症易感性和进化限制:来自1127名癌症儿童生殖系基因组的新经验。

IF 10.2 1区 医学 Q1 ONCOLOGY
Ulrik Kristoffer Stoltze,Thomas van Overeem Hansen,Jon Foss-Skiftesvik,Anna Byrjalsen,Kasper Amund Henriksen,Adrian Otamendi Laspiur,Anne-Marie Gerdes,Sisse Rye Ostrowski,Erik Sørensen,Mads Bak,Charlotte Kvist Lautrup,Karen Grønskov,Elena Papaleo,Henrik Hasle,Torben Stamm Mikkelsen,Peder Wehner,Astrid Brix Saksager,Mette Klarskov Andersen,Mimi Kjærsgaard,Tina Duelund Hjortshøj,Jane Hübertz Frederiksen,David Scheie,Tina Elisabeth Olsen,Ruta Tuckuviene,Marianne Olsen,Zeynep Tümer,Rene Mathiasen,Jesper Brok,Astrid Sehested,Bram L Gorissen,Simon Rasmussen,Konrad J Karczewski,Lisa L Hjalgrim,Karin A W Wadt,Kjeld Schmiegelow
{"title":"儿童癌症易感性和进化限制:来自1127名癌症儿童生殖系基因组的新经验。","authors":"Ulrik Kristoffer Stoltze,Thomas van Overeem Hansen,Jon Foss-Skiftesvik,Anna Byrjalsen,Kasper Amund Henriksen,Adrian Otamendi Laspiur,Anne-Marie Gerdes,Sisse Rye Ostrowski,Erik Sørensen,Mads Bak,Charlotte Kvist Lautrup,Karen Grønskov,Elena Papaleo,Henrik Hasle,Torben Stamm Mikkelsen,Peder Wehner,Astrid Brix Saksager,Mette Klarskov Andersen,Mimi Kjærsgaard,Tina Duelund Hjortshøj,Jane Hübertz Frederiksen,David Scheie,Tina Elisabeth Olsen,Ruta Tuckuviene,Marianne Olsen,Zeynep Tümer,Rene Mathiasen,Jesper Brok,Astrid Sehested,Bram L Gorissen,Simon Rasmussen,Konrad J Karczewski,Lisa L Hjalgrim,Karin A W Wadt,Kjeld Schmiegelow","doi":"10.1158/1078-0432.ccr-25-0153","DOIUrl":null,"url":null,"abstract":"BACKGROUND\r\nCancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs.\r\n\r\nMETHOD\r\nGermline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age. Evolution-guided burden analysis of private germline variants in constrained genes compared with 125,748 gnomAD exomes.\r\n\r\nRESULTS\r\nAcross a total of 1,127 participants, 16% carried a pathogenic variant in at least one CPS gene. After genotype-phenotype matching, 9 % of children in the prospective cohort (n=651) carried a variant considered causative, a rate deemed significantly higher than previous studies (RR=1.54,95%CI1.37-1.75,p=1e-14). As predicted for a disease subject to negative Darwinian selective pressure, compared to reference adults, we found a significant excess of loss-of-function (LoF) variants in the 1,500 most constrained genes (RR=1.54,99%CI 1.21-1.95,p=4e-6). Surprisingly, this excess was greater than expected, leaving a significant residual enrichment of pLoF variants in genes evolutionarily considered the least tolerant to damage (RR=1.41,99%CI1.09-1.80,p=4e-4).\r\n\r\nCONCLUSION\r\nThe high frequency of LoF variants, including in known CPSs, emphasizes the need for systematic and extensive germline genomic mapping as part of the diagnostic work-up of childhood cancer patients and linkage of such data to disease and response phenotypes to guide future pediatric oncological care, and ultimately paving the way for pre-diagnostic interventional measures.","PeriodicalId":10279,"journal":{"name":"Clinical Cancer Research","volume":"23 1","pages":""},"PeriodicalIF":10.2000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Childhood Cancer Predisposition and Evolutionary Constraints: Novel lessons from Germline Genomes from 1,127 Children with Cancer.\",\"authors\":\"Ulrik Kristoffer Stoltze,Thomas van Overeem Hansen,Jon Foss-Skiftesvik,Anna Byrjalsen,Kasper Amund Henriksen,Adrian Otamendi Laspiur,Anne-Marie Gerdes,Sisse Rye Ostrowski,Erik Sørensen,Mads Bak,Charlotte Kvist Lautrup,Karen Grønskov,Elena Papaleo,Henrik Hasle,Torben Stamm Mikkelsen,Peder Wehner,Astrid Brix Saksager,Mette Klarskov Andersen,Mimi Kjærsgaard,Tina Duelund Hjortshøj,Jane Hübertz Frederiksen,David Scheie,Tina Elisabeth Olsen,Ruta Tuckuviene,Marianne Olsen,Zeynep Tümer,Rene Mathiasen,Jesper Brok,Astrid Sehested,Bram L Gorissen,Simon Rasmussen,Konrad J Karczewski,Lisa L Hjalgrim,Karin A W Wadt,Kjeld Schmiegelow\",\"doi\":\"10.1158/1078-0432.ccr-25-0153\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND\\r\\nCancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs.\\r\\n\\r\\nMETHOD\\r\\nGermline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age. Evolution-guided burden analysis of private germline variants in constrained genes compared with 125,748 gnomAD exomes.\\r\\n\\r\\nRESULTS\\r\\nAcross a total of 1,127 participants, 16% carried a pathogenic variant in at least one CPS gene. After genotype-phenotype matching, 9 % of children in the prospective cohort (n=651) carried a variant considered causative, a rate deemed significantly higher than previous studies (RR=1.54,95%CI1.37-1.75,p=1e-14). As predicted for a disease subject to negative Darwinian selective pressure, compared to reference adults, we found a significant excess of loss-of-function (LoF) variants in the 1,500 most constrained genes (RR=1.54,99%CI 1.21-1.95,p=4e-6). Surprisingly, this excess was greater than expected, leaving a significant residual enrichment of pLoF variants in genes evolutionarily considered the least tolerant to damage (RR=1.41,99%CI1.09-1.80,p=4e-4).\\r\\n\\r\\nCONCLUSION\\r\\nThe high frequency of LoF variants, including in known CPSs, emphasizes the need for systematic and extensive germline genomic mapping as part of the diagnostic work-up of childhood cancer patients and linkage of such data to disease and response phenotypes to guide future pediatric oncological care, and ultimately paving the way for pre-diagnostic interventional measures.\",\"PeriodicalId\":10279,\"journal\":{\"name\":\"Clinical Cancer Research\",\"volume\":\"23 1\",\"pages\":\"\"},\"PeriodicalIF\":10.2000,\"publicationDate\":\"2025-08-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1158/1078-0432.ccr-25-0153\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1078-0432.ccr-25-0153","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:儿童发病的癌症易感综合征(cps)是已知的儿童恶性肿瘤的主要原因,并且越来越多地指导儿科肿瘤学的临床策略。cps处于进化的负选择压力下,但儿童癌症研究迄今未能研究基因组进化指标作为预测外显率和揭示新型cps的指导。方法:采用生殖系全基因组测序(WGS)对18岁前诊断为癌症的个体进行5年前瞻性、注册验证、全国队列研究。125,748个gnomAD外显子组中受限制基因中私有种系变异的进化引导负担分析结果在总共1127名参与者中,16%的人携带至少一个CPS基因的致病性变异。基因型-表型匹配后,前瞻性队列中9%的儿童(n=651)携带一种被认为是致病的变异,这一比率被认为显著高于以往的研究(RR=1.54,95%CI1.37-1.75,p=1e-14)。正如预测的那样,与参考成人相比,我们发现在1500个最受限制的基因中,功能丧失(LoF)变异明显过量(RR=1.54,99%CI 1.21-1.95,p=4e-6)。令人惊讶的是,这种过剩比预期的要大,在进化上被认为最不耐损伤的基因中留下了显著的pLoF变体残余富集(RR=1.41,99%CI1.09-1.80,p=4e-4)。结论LoF变异的高频率,包括已知的cps,强调需要系统和广泛的种系基因组图谱作为儿童癌症患者诊断工作的一部分,并将这些数据与疾病和反应表型联系起来,以指导未来的儿科肿瘤护理,并最终为诊断前干预措施铺平道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Childhood Cancer Predisposition and Evolutionary Constraints: Novel lessons from Germline Genomes from 1,127 Children with Cancer.
BACKGROUND Cancer predisposition syndromes (CPSs) with pediatric onset are the leading known cause of childhood malignancies and are increasingly guiding clinical strategies in pediatric oncology. CPSs are placed under evolutionary negative selective pressure, but pediatric pancancer studies have so far failed to investigate genomic evolutionary metrics as a guide to predict penetrance and reveal novel CPSs. METHOD Germline whole-genome sequencing (WGS) in a 5-year prospective, registry-validated, nationwide cohort of individuals diagnosed with cancer before 18 years of age. Evolution-guided burden analysis of private germline variants in constrained genes compared with 125,748 gnomAD exomes. RESULTS Across a total of 1,127 participants, 16% carried a pathogenic variant in at least one CPS gene. After genotype-phenotype matching, 9 % of children in the prospective cohort (n=651) carried a variant considered causative, a rate deemed significantly higher than previous studies (RR=1.54,95%CI1.37-1.75,p=1e-14). As predicted for a disease subject to negative Darwinian selective pressure, compared to reference adults, we found a significant excess of loss-of-function (LoF) variants in the 1,500 most constrained genes (RR=1.54,99%CI 1.21-1.95,p=4e-6). Surprisingly, this excess was greater than expected, leaving a significant residual enrichment of pLoF variants in genes evolutionarily considered the least tolerant to damage (RR=1.41,99%CI1.09-1.80,p=4e-4). CONCLUSION The high frequency of LoF variants, including in known CPSs, emphasizes the need for systematic and extensive germline genomic mapping as part of the diagnostic work-up of childhood cancer patients and linkage of such data to disease and response phenotypes to guide future pediatric oncological care, and ultimately paving the way for pre-diagnostic interventional measures.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Cancer Research
Clinical Cancer Research 医学-肿瘤学
CiteScore
20.10
自引率
1.70%
发文量
1207
审稿时长
2.1 months
期刊介绍: Clinical Cancer Research is a journal focusing on groundbreaking research in cancer, specifically in the areas where the laboratory and the clinic intersect. Our primary interest lies in clinical trials that investigate novel treatments, accompanied by research on pharmacology, molecular alterations, and biomarkers that can predict response or resistance to these treatments. Furthermore, we prioritize laboratory and animal studies that explore new drugs and targeted agents with the potential to advance to clinical trials. We also encourage research on targetable mechanisms of cancer development, progression, and metastasis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信